Nanoparticles as agents targeting cholesterol crystallization in atherosclerosis; Medical Hypotheses; Vol. 102

Bibliografski detalji
Parent link:Medical Hypotheses
Vol. 102.— 2017.— [P. 19–22]
Glavni autor: Anfinogenova Ya. J. Yana Jonovna
Autor kompanije: Национальный исследовательский Томский политехнический университет (ТПУ) Физико-технический институт (ФТИ) Кафедра иностранных языков физико-технического института (ИЯФТ)
Daljnji autori: Shvedova M. V. Mariya Vitaljevna, Popov M. V. Sergey Valentinovich
Sažetak:Title screen
This article introduces a hypothesis on nanoparticle-mediated modulation of cholesterol crystal behaviour in the atherosclerotic plaques. The role of cholesterol crystals in progression of atherosclerosis is emphasized. Proposed mechanism of spontaneous cholesterol crystal formation in the organism is discussed. Mechanisms and factors associated with the nanoparticle-mediated modulation of cholesterol crystal behaviour are proposed. Authors hypothesize that specially designed nanoparticles may therapeutically modulate cholesterol crystal behaviour in atherosclerosis. Nano-sized agents used in stent coatings and imaging techniques can possibly prevent cholesterol crystallization in the diseased vessels. On the other hand, new nanotechnologies should be implemented with caution as certain types of nanoparticles could become crystal seeds for cholesterol deposited in the atherosclerotically damaged vascular walls causing destabilization of the plaques. Studying nanoparticle-induced alterations of cholesterol crystal formation requires multidisciplinary approach involving biomedical researchers, computer scientists, and physical chemists specializing in crystal growth. The proposed hypothesis on nanoparticle-mediated modulation of cholesterol crystal behaviour may be relevant to other medical conditions including gallbladder stones, arthritis, and ophthalmological diseases such as synchysis scintillans.
Режим доступа: по договору с организацией-держателем ресурса
Jezik:engleski
Izdano: 2017
Teme:
Online pristup:https://doi.org/10.1016/j.mehy.2017.03.002
Format: Elektronički Poglavlje knjige
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=654494

MARC

LEADER 00000naa0a2200000 4500
001 654494
005 20250312113622.0
035 |a (RuTPU)RU\TPU\network\20090 
090 |a 654494 
100 |a 20170428d2017 k||y0rusy50 ba 
101 0 |a eng 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Nanoparticles as agents targeting cholesterol crystallization in atherosclerosis  |f Ya. J. Anfinogenova, M. V. Shvedova, M. V. Popov 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References.: p. 22 (28 tit.)] 
330 |a This article introduces a hypothesis on nanoparticle-mediated modulation of cholesterol crystal behaviour in the atherosclerotic plaques. The role of cholesterol crystals in progression of atherosclerosis is emphasized. Proposed mechanism of spontaneous cholesterol crystal formation in the organism is discussed. Mechanisms and factors associated with the nanoparticle-mediated modulation of cholesterol crystal behaviour are proposed. Authors hypothesize that specially designed nanoparticles may therapeutically modulate cholesterol crystal behaviour in atherosclerosis. Nano-sized agents used in stent coatings and imaging techniques can possibly prevent cholesterol crystallization in the diseased vessels. On the other hand, new nanotechnologies should be implemented with caution as certain types of nanoparticles could become crystal seeds for cholesterol deposited in the atherosclerotically damaged vascular walls causing destabilization of the plaques. Studying nanoparticle-induced alterations of cholesterol crystal formation requires multidisciplinary approach involving biomedical researchers, computer scientists, and physical chemists specializing in crystal growth. The proposed hypothesis on nanoparticle-mediated modulation of cholesterol crystal behaviour may be relevant to other medical conditions including gallbladder stones, arthritis, and ophthalmological diseases such as synchysis scintillans. 
333 |a Режим доступа: по договору с организацией-держателем ресурса 
461 |t Medical Hypotheses 
463 |t Vol. 102  |v [P. 19–22]  |d 2017 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a наночастицы 
610 1 |a атеросклероз 
610 1 |a холестерин 
610 1 |a кристаллы 
700 1 |a Anfinogenova  |b Ya. J.  |c Linguist  |c Lecturer of Tomsk Polytechnic University, Doctor of medical sciences  |f 1970-  |g Yana Jonovna  |3 (RuTPU)RU\TPU\pers\33592 
701 1 |a Shvedova  |b M. V.  |g Mariya Vitaljevna 
701 1 |a Popov  |b M. V.  |g Sergey Valentinovich 
712 0 2 |a Национальный исследовательский Томский политехнический университет (ТПУ)  |b Физико-технический институт (ФТИ)  |b Кафедра иностранных языков физико-технического института (ИЯФТ)  |3 (RuTPU)RU\TPU\col\18736 
801 2 |a RU  |b 63413507  |c 20170428  |g RCR 
856 4 |u https://doi.org/10.1016/j.mehy.2017.03.002 
942 |c CF